Skip to main content
. 2017 Jul 25;18(3):229–234. doi: 10.14744/AnatolJCardiol.2017.7540

Table 4.

Comparison of the markers with respect to the Amplatzer, Lifetech CeraFlex, and Occlutech Figulla Flex II devices before and after transcatheter ASD closure

Parameters Atrial septal occluders P

Amplatzer Lifetech CeraFlex Occlutech Figulla Flex II
PDGF, pg/mL
 Before 0.079±0.11 0.076±0.04 0.117±0.11 0.469
 After 0.134±0.03 0.145±0.05 0.171±0.07 0.207
TGF-β1, pg/mL
 Before 0.109±0.13 0.114±0.09 0.223±0.36 0.324
 After 0.286±0.25 0.225±0.26 0.295±0.27 0.748
IL-1α, pg/mL
 Before 0.016±0.01 0.016±0.01 0.014±0.01 0.731
 After 0.013±0.01 0.017±0.01 0.012±0.01 0.448
VEGF, pg/mL
 Before 0.101±0.09 0.076±0.02 0.209±0.24 0.058
 After 0.444±0.43 0.591±0.43 0.563±0.38 0.601
FGF-2, pg/mL
 Before 0.165±0.19 0.124±0.12 0.232±0.27 0.378
 After 0.341±0.21 0.328±0.19 0.256±0.21 0.499
MMP-9, pg/mL
 Before 0.080±0.03 0.140±0.22 0.097±0.03 0.436
 After 0.097±0.02 0.094±0.03 0.099±0.03 0.908
FGF-1, pg/mL
 Before 0.144±0.14 0.129±0.09 0.148±0.15 0.926
 After 0.138±0.10 0.120±0.10 0.135±0.18 0.935

FGF - fibroblast growth factor; MMP-9 - matrix metalloproteinase-9, PDGF - platelet-derived growth factor; TGF-β1 - transforming growth factor-β1; IL-1α - interleukin-1α; VEGF - vascular endothelial growth factor